You tell an artificial intelligence agent, an AI capable of autonomous reasoning and multistep actions, “Find me a shirt for less than $30, but do not buy it.” The agent finds one – and places the order
ADAR1 Capital Management, LLC, a 10% owner and director of NextCure, Inc. (), acquired common stock totaling $1,624,120 through multiple transactions on July 30 and July 31, 2026. The investment firm purchased a total of 329,153 shares of NextCure common stock. The
Amit Kumar, Chief Executive Officer and a Director at Anixa Biosciences Inc (), acquired 5,000 shares of the company’s common stock on July 31, 2026. The transaction totaled $17,350, with shares purchased at a price of $3.47 each. The purchase
John P. Brase, President and CEO of Conagra Brands Inc. (), acquired 35,000 shares of the company’s common stock on July 17, 2026, for a total value of $510,632. The shares were purchased at prices ranging from $14.575 to $14.59 per
Snehal Patel, CEO and CFO of Greenwich LifeSciences, Inc. (), recently purchased company stock valued at $20,430. The transaction occurred on July 27, 2026. Mr. Patel acquired 1,500 shares of Greenwich LifeSciences common stock at a price of $13.62 per share.
RA Capital Management, L.P., a reporting person identified as both a director and a 10% owner of Artiva Biotherapeutics, Inc. (), acquired 41,319 shares of the company’s common stock on July 24, 2026. The total value of these
Troy Cox, a director at MapLight Therapeutics, Inc. (), recently acquired 15,620 shares of the company’s common stock for a total value of $148,702. The transaction took place on July 28, 2026. The shares were purchased at a weighted
Curtland E. Fields, a director at Kearny Financial Corp. (), purchased shares of the company’s common stock on July 27, 2026. The transactions totaled $138,273, with prices ranging from $9.395 to $9.41 per share. The director made four separate purchases,
Dwight Eric Smith, a director at Peoples Bancorp Inc. (), recently purchased shares of the company’s common stock. The transaction took place on July 23, 2026, and involved the acquisition of 1,000 shares. The shares were purchased at
Nancy Koskey Patzwahl, a director at Rhinebeck Bancorp, Inc. (), recently purchased shares of the company’s common stock. On July 22, 2026, Ms. Patzwahl acquired 25,000 shares at a price of $11.94 per share, totaling $298,500. Following this transaction, Ms.
